CEN BIOTECH, INC.
CIK 0001653821
Revenue (TTM)
$1.29M
Q3 Nov 2022
Net Income (TTM)
−$1.73M
−232.7% YoY
Q3 Nov 2022
EPS Diluted (TTM)
−$0.45
−200.0% YoY
Q3 Nov 2022
Gross Margin
—
Q3 Nov 2022
Operating Margin
-121.7%
Q3 Nov 2022
Net Margin
-133.7%
Q3 Nov 2022
Free Cash Flow (TTM)
−$403.05K
Q3 Nov 2022
Cash
$148.15K
Q3 Nov 2022
Total Debt
$1.69M
Q3 Nov 2022
Shares Outstanding
64.13M sh
Q3 Nov 2022
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.